baber/WOPTO huggingface dataset:
Patent AU-670369-B2 (AU)
Title: Apparatus and method for making absorbent products containing a first material dispersed within a second material
Inventor: GRIFFOUL THOMAS
IPC: A61F13/15
Filed: 1994-05-26
Granted: 1996-07-11
Abstract: An apparatus (1) and method for making absorbent products (17) in which a first material (10), such as absorbent fluff formed from wood pulp, is introduced into a vacuum forming chamber (12). A portion of the fluff is deposited into the cavity of a mold (19) transported through the forming chamber (12) by a forming wheel (7) so as to form a layer of pure fluff within the bottom of the mold cavity (20). A second material (11), such as superabsorbent particles or heat stabilized fibers, is introduced into the forming chamber (12) so that streams of the first (10) and second (11) materials collide within a mixing zone (24). As the mold (19) continues its travel through the forming chamber (12), a mixture of first (10) and second (11) materials from the mixing zone (24) is deposited within the mold cavity (20), thereby filling it. The portion of the mixture that extends above the surface of the mold (19) is scraped off by a scarfing brush (13,14) that directs the mixture back into the mixing zone (24), thereby creating turbulence that ensures thorough mixing of the two materials. The result is an absorbent product having a first layer formed by pure first material (10) and a second layer formed by a mixture of the first (10) and second (11) materials. <IMAGE>
Patent AU-545181-B2 (AU)
Title: Hybridoma for producing monoclonal antibodies
Inventor: KUNG PATRICK CHUNG-SHU
IPC: C12N15/00
Filed: 1980-12-02
Granted: 1985-07-04
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 10% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF, mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent AU-582920-B2 (AU)
Title: Continuous release pharmaceutical compositions
Inventor: HUTCHINSON FRANCIS GOWLAND
IPC: C08G63/08
Filed: 1986-11-10
Granted: 1989-04-13
Abstract: Pharmaceutical compositions, comprising a polylactide and a pharmacologically active, acid stable polypeptide, which when placed in an aqueous physiological environment release the polypeptide at an approximately constant rate in an essentially monophasic manner, with a minimal, or no induction period prior to the release; polylactides suitable for use in said compositions; and a method for the manufacture of such polylactides.
Patent AU-633375-B2 (AU)
Title: Method for preparation of taxol using an oxazinone
IPC: C07D265/06
Filed: 1990-11-08
Granted: 1993-01-28
Abstract: Process for the preparation of a taxol intermediate comprising contacting an alcohol with an oxazinone having the formula: <CHEM> wherein R1 is aryl, heteroaryl, alkyl, alkenyl, alkynyl or OR7 wherein R7 is alkyl, alkenyl, alkynyl, aryl or heteroaryl; R2 and R5 are independently selected from hydrogen, alkyl alkenyl, alkynyl, aryl, heteroaryl, and OR8 wherein R8 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, or hydroxyl protecting group; and R3 and R6 are independently selected from hydrogen, alkyl, alkenyl, alkynyl, aryl and heteroaryl.
Patent AU-680248-B2 (AU)
Title: Medical devices and materials having enhanced magnetic images visibility
Inventor: YOUNG STUART W
IPC: A61L29/14
Filed: 1994-04-12
Granted: 1997-07-24
Abstract: Catheters and other medical devices include a non-metallic member having paramagnetic ionic particles fixedly incorporated therethrough in order to provide enhanced detectability when viewed by magnetic imaging regardless of the orientation of the non-metallic member in the magnetic field. Catheters are usually formed from polymeric tubing, and the paramagnetic ionic particles are usually formed from paramagnetic ions incorporated with water or other proton-donating fluid into carrier particles, such as zeolites, molecular sieves, clays, synthetic ion exchange resins, and microcapsules. Catheters and other medical devices include a non-metallic member having small iron and/or superparamagnetic particles fixedly incorporated therethrough or thereover in order to provide enhanced detectability when viewed by magnetic imaging. Catheters are usually formed from polymeric tubing, and the iron and/or superparamagnetic particles at or near the surface of the catheter interact with the water protons of the surrounding patient's body to provide image enhancement regardless of the orientation of the polymeric or other non-metallic material in the magnetic field.
Patent AU-683477-B2 (AU)
Title: Instrument for anterior intervertebral disk surgery
Inventor: BEURIER JACQUES PIERRE
IPC: A61B17/00
Filed: 1994-06-16
Granted: 1997-11-13
Abstract: PCT No. PCT/FR94/00728 Sec. 371 Date Jul. 18, 1996 Sec. 102(e) Date Jul. 18, 1996 PCT Filed Jun. 16, 1994 PCT Pub. No. WO95/00197 PCT Pub. Date Jan. 5, 1995An instrument including a guide needle (1), at least two nesting concentric tubes (2-6) placed over the guide needle, and an outer working tube (7) concentric with said tubes. The tip of the outer tube (7) is provided with a device (11) for spacing apart the bodies of vertebrae adjacent to the disk and keeping them apart during surgery, while its proximal end is provided with a hand grip (8). Anterior percutaneous nuclear incision performed with said instrument enables puncture of the disk, and particularly excision of the nucleus, to be performed easily, more quickly and more effectively than with the conventional posterolateral approach, while avoiding any damage to the anatomical environment of the patient.
Patent AU-726467-B2 (AU)
Title: Magnetic resonance blood pool agents
Inventor: WOULFE STEVEN R
IPC: A61K49/00
Filed: 1997-11-12
Granted: 2000-11-09
Abstract: The present invention provides compositions comprising contrast agents capable of binding non-covalently to blood proteins. The compositions of the invention provide increased residence time of contrast agents in the vasculature, thus providing effective blood pool contrast agents. The invention also provides methods for imaging a patient comprising administering a composition of the invention to a patient and obtaining an image.
Patent AU-724257-B2 (AU)
Title: Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
Inventor: HUBER BRIGITTE T
IPC: C07K14/73
Filed: 1998-04-30
Granted: 2000-09-14
Abstract: A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a concentration below 10<SUP>-8</SUP>M, wherein the compound is characterized in that: (a) it is capable of crossing the membrane of T-cells to enter the cytoplasm, (b) it binds to the dipeptidase activity at a concentration of below 10<SUP>-8</SUP>M, and thus (c) stimulates proliferation of the T-cells at that concentration.
Patent AU-776093-B2 (AU)
Title: System and method for accurately predicting signal to interference and noise ratio to improve communications system performance
Inventor: WU QIANG
IPC: H04B17/00
Filed: 2000-09-12
Granted: 2004-08-26
Abstract: A system for providing an accurate prediction of a signal-to-interference noise ratio is described. The system includes a first circuit for receiving a signal transmitted across a channel via an external transmitter. A second circuit generates a sequence of estimates of signal-to-interference noise ratio based on the received signal. A third circuit determines a relationship between elements of the sequence of estimates. A fourth circuit employs the relationship to provide a signal-to-interference noise ratio prediction for a subsequently received signal. In the illustrative embodiment, the inventive system further includes a circuit for generating a data rate request message based on the signal-to-noise ratio prediction. A special transmitter transmits the data rate request message to the external transmitter. In the specific embodiment, the relationship between elements of the sequence of estimates is based on an average of the elements of the sequence of estimates. The third circuit includes a bank of filters for computing the average. The bank of filters includes finite impulse response filters. Coefficients of the transfer functions associated with each filter in the bank of filters are tailored for different fading environments. The different fading environments include different Rayleigh fading environments, one environment associated with a rapidly moving system, a second environment associated with a slow moving system, and a third system associated with a system moving at a medium velocity. A selection circuit is connected to each of the filter banks and selects an output from one of the filters in the filter bank. The selected output is associated with a filter having a transfer function most suitable to a current fading environment.
Patent AU-696929-B2 (AU)
Title: Electrostatic spraying device
Inventor: JEFFERIES ANDREW
IPC: B05B5/16
Filed: 1994-08-22
Granted: 1998-09-24
Abstract: An electrostatic spraying device is provided with a container (16) for the liquid to be sprayed and a capillary structure (22) extending into the container. To maintain a substantially constant liquid level at the location where liquid is drawn into the capillary structure, the container is partitioned into two chambers one (68) of which is isolated from atmosphere and the other (66) of which is in communication with atmosphere. The capillary structure (22) extends through one chamber and the arrangement is such that the liquid level at the location where the capillary structure communicates with the liquid is maintained substantially constant over a wide range of variation of the liquid level within the other chamber. The upper end of the capillary structure may be provided with an oblique end face (50; 70, 72) to facilitate dispersal of the spray into the surroundings. <IMAGE>
Patent AU-689490-B2 (AU)
Title: Therapeutic peptide derivatives
Inventor: KIM SUN HYUK
IPC: A61P1/12
Filed: 1994-08-08
Granted: 1998-04-02
Abstract: Peptide derivatives containing one or more substituents separately linked by an amide, amino or sulfonamide bond to an amino group on either the N-terminal end or side chain of a biologically active peptide moiety. The peptide derivatives have relatively enhanced biological activity when compared to the corresponding peptide alone.
Patent AU-733784-B2 (AU)
Title: Blister card package for holding and displaying small items
Inventor: HIPPELY KEITH ALAN
IPC: B65D75/36
Filed: 1998-05-27
Granted: 2001-05-24
Abstract: A generally planar substantially rigid backing supports a transparent plastic blister on the front surface thereof. The blister defines an open rear portion and an encircling attachment flange. The lower edge of the attachment flange defines interleaved notches and tabs extending downwardly. The blister further defines a rib having an interior groove formed therein extending along each side and across the front portion of the blister. A generally planar support sheet formed of a rigid material defines a plurality of upwardly extending retainers having engagement apparatus formed therein. A cosmetic card formed of a decorative material defines a plurality of slots aligned with the retainers and is received upon the support sheet with the retainers passing through the slots. The retainers engage the to-be-packaged articles and secure them upon the cosmetic card. The support sheet includes a plurality of interleaved tabs and notches extending downwardly from the rear edge thereof. The tabs and notches of the blister and support sheet are offset to allow interleaving thereof and common attachment to the backing to secure the blister to the rigid backing.
Patent AU-729495-B2 (AU)
Title: Phosphodiesterase 4-inhibiting diazepinoindolones
Inventor: PASCAL YVES
IPC: C07D519/00
Filed: 1998-04-30
Granted: 2001-02-01
Abstract: The present invention presents compounds that inhibit phosphodiesterase 4 having Formula (I). The present invention also provides methods of using the compounds of Formula (I) to prevent or treat asthma, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disorders, pulmonary hypertension, liver injury, bone loss, septic shock, or multiple sclerosis, and to pharmaceutical compositions that contain the compounds of Formula (I).
Patent AU-742307-B2 (AU)
Title: Improved geotextile container and method of producing same
Inventor: BRADLEY ANTHONY S
IPC: B65D30/04
Filed: 1998-05-29
Granted: 2001-12-20
Abstract: An improved geotextile container of the type for maintaining fill material includes a geotextile fabric configured into a tubular shape and having stitched, multi-layer, flanged seams with the stitched flange disposed inside the container. Due to this construction, outwardly directed forces imparted by the fill material will be directed against the stitching. An embodiment with an outer layer of geotextile material has an inner liner of geotextile material.
Patent AU-598583-B2 (AU)
Title: 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents
Inventor: YASUDA KIKUO
IPC: C07D237/04
Filed: 1987-09-07
Granted: 1990-06-28
Abstract: A pyridazinone derivative represented by the following general formula <CHEM> wherein R1 represents a hydrogen atom or a methyl group, either one of R2, R3 and R4 represents a hydrogen atom and the remaining two of them represent a lower alkyl group, a trifluoromethyl group, a halogen atom, a cyano group or a nitro group, or a salt thereof. The compounds are useful as antihypertensive agents.
Patent AU-680303-B2 (AU)
Title: Novel phenylethyl and phenylpropylamines
Inventor: BENGTSSON STEFAN
IPC: A61K31/4015
Filed: 1994-09-16
Granted: 1997-07-24
Abstract: PCT No. PCT/SE94/00860 Sec. 371 Date Oct. 26, 1994 Sec. 102(e) Date Oct. 26, 1994 PCT Filed Sep. 16, 1994 PCT Pub. No. WO95/09835 PCT Pub. Date Apr. 13, 1995Compounds of the general formula   <IMAGE>   or pharmaceutically acceptable salts thereof, wherein Z is a saturated or unsaturated 3 to 6 carbon chain, m is 2 or 3, R1 is a hydrogen atom, or a straight or branched C1-4 alkyl group, R2, R3 and R13 are situated in the ortho, meta, or para position of the phenyl ring and are the same or different and selected from the following groups: H, OH, OR14, halogen, CO2R9, CN, CF3, NO2, NH2, COCH3,OSO2CF3,OSO2CH3,CONR10R11, OCOR12, wherein R9, R12 and R14 is a straight or branched C1-4 alkyl group, R10 and R11 are the same or different and represents hydrogen or a straight or branched C1-6 alkyl group, R is 1)   <IMAGE>    or   <IMAGE>   or   <IMAGE>   or   <IMAGE>   wherein the variables are defined in the specification,  processes for their preparation, pharmaceutical preparations containing them and the use of the compounds in the treatment psychiatric disorders.
Patent AU-732722-B2 (AU)
Title: 2-{4-{4-(4,5-dichloro-2- methylimidazol-1-yl)butyl} -1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
Inventor: MERCE-VIDAL RAMON
IPC: C07D239/30
Filed: 1998-05-28
Granted: 2001-04-26
Abstract: 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, and its physiologically acceptable salts; pharmaceutical compositions containing these compounds, and a method of treating vertigo, travel sickness, nausea, depression, anxiety, gastric acid secretion, obsessive/compulsive disorders, panic attacks or sleep apnea using these compounds are disclosed.
Patent AU-753809-B2 (AU)
Title: Recombinant adenoviral vectors comprising a splicing sequence
Inventor: MEHTALI MAJID
IPC: A61P43/00
Filed: 1998-06-02
Granted: 2002-10-31
Abstract: The invention concerns a recombinant adenoviral vector driving from an adenovirus genome at least by deleting all or part of the E1 region, the adenoviral vector comprising an expression cassette of a gene of interest placed under the control of elements necessary for its expression in a host cell or a host organism, the elements required for its expression including at least a splicing sequence. The invention is characterized in that the splicing sequence is derived from a eukaryotic nuclear gene selected among the ovalbumen genes, beta or beta-globine, collagen and factor VIII of mammals or a synthetic splicing sequence. The invention also concerns a host cell and an infectious viral particle comprising such a vector, a method for preparing such a particle and their therapeutic or prophylactic use. The invention further concerns a pharmaceutical composition containing the adenoviral vector, the host cell or the viral particle.
Patent AU-634077-B2 (AU)
Title: Retarders for hardening phenolic resins
IPC: C08K3/22
Filed: 1991-07-23
Granted: 1993-02-11
Abstract: There are disclosed methods and compositions for retarding the room temperature gelation and eventual hardening of phenolic resole resins when such resins are mixed with lightburned magnesium oxide or magnesium hydroxide hardening agents with or without an ester functional hardening agent. Retardation of gelation and hardening is achieved by incorporating into said mixture a retarder compound such as one which decreases the solubility of magnesium in said mixture. Additionally, hardening at higher temperatures, thermal curing, coated abrasives, polymer concrete, and other methods and compositions of this invention are disclosed.
Patent AU-644672-B2 (AU)
Title: Method and device for manufacturing a semi-ferritic stainless steel strip from molten metal
Inventor: DEMAREZ PHILIPPE
IPC: C21D1/607
Filed: 1991-08-13
Granted: 1993-12-16
Abstract: According to this method, the metal is solidified in a continuous-casting ingot mould consisting of two cooled rolls (2) rotating in opposite directions and arranged opposite each other so as to define a casting space between them, a solidified steel strip (3) is extracted continuously from the ingot mould, and, under the ingot mould, the said strip is subjected to a quenching medium (6) in order to cool it sufficiently rapidly in order to prevent the formation of austenite. This medium may consist of a quenching bath, placed in a container (4) arranged under the rolls (2), and whose bottom is pierced with an opening (5) for the passage of the solidified strip (3). It may also consist of an inert gas in the liquid state sprayed onto the product by nozzles. The steel strips obtained are easier to trim and to coil on exit from the casting line, by virtue of the absence of martensite in the ferritic matrix. 
<IMAGE>
Patent AU-656155-B2 (AU)
Title: A method for sealing of a mass of waste
Inventor: COTE PIERRE LUCIEN
IPC: B09B1/00
Filed: 1991-10-22
Granted: 1995-01-27
Abstract: PCT No. PCT/NL91/00209 Sec. 371 Date Apr. 22, 1993 Sec. 102(e) Date Apr. 22, 1993 PCT Filed Oct. 22, 1991 PCT Pub. No. WO92/06801 PCT Pub. Date Apr. 30, 1992.A new method for sealing off a mass of waste which comprises surrounding the mass of waste, stabilized waste or its placement side with a least one substantially continuous layer of porous material, the layer defining a substantially continuous, waste-encompassing interface, and providing a sufficient amount of an interactive reagent on either side of the interface for the reagent upon placement to diffuse towards each other and to form a precipitate filling the pores of the porous material substantially along the interface thereby forming a waste-encompassing layer of reduced permeability. The special benefit of this method is that after a rupture of the seal the interactive reagents form a new seal, thus preventing loss of noxious substances through the rupture.
Patent AU-743802-B2 (AU)
Title: Device and method for sealing levelling door aperture of a coke oven chamber
Inventor: GIERTZ HANS-JOSEF
IPC: C10B27/04
Filed: 1998-07-06
Granted: 2002-02-07
Abstract: The invention relates to a device for sealing a leveling door aperture of a coke oven chamber when loading bulk coking coal. The device includes a housing and a leveling door aperture, a leveling arm, composed of at least side panels and cross spacers connecting the side panels, is guided through the housing and the leveling door aperture. The leveling arm supports means for sealing a cross-sectional area of the leveling door aperture or upstream the leveling door aperture. A controllable or adjustable exhauster is joined to the housing and a measurement point is provided for flow rate measurement.
Patent AU-782933-B2 (AU)
Title: Device for adjusting the working height of a crop pick-up
Inventor: VIAUD JEAN
IPC: A01D89/00
Filed: 2001-11-13
Granted: 2005-09-08
Abstract: A large round baler is equipped with a pick-up mounted to the baler frame for being raised and lowered relative to the ground by operation of a hydraulic cylinder. The pick-up is maintained at a desired working height by a control arrangement including at least one height sensor which sends a signal corresponding to the instant height of the pick-up above the ground to a signal processing unit which compares the height signal with a stored value corresponding to a desired height, the signal processing unit the sending a control signal for controlling a solenoid-operated valve in such a way that the hydraulic cylinder is caused to move the pick-up in the required direction for maintaining the desired height.
Patent BG-61491-B2 (BG)
Title: Fluoroalkoxy amino triazines for control of weeds in sugar beets
Inventor: MOON MARKUS P
IPC: C07D251/52
Filed: 1992-03-26
Abstract: This invention comprises novel fluoroalkoxy amino triazines, agriculturally, suitable compositions containing them, and their method-of-use as preemergence and/or postemergence herbicides or plant growth regulants.
Patent BG-60937-B2 (BG)
Title: Tetrahydronaphthalenes and medicamentous forms containing them
Inventor: BRANCA QUIRICO
IPC: C07D487/04
Filed: 1994-02-14
Abstract: Compounds of the formula    <IMAGE>  I  wherein R is lower-alkyl, R1 is halogen, R2 is C1-C12-alkyl, R3 is hydroxy, lower-alkoxy, lower-alkyl-carbonyloxy, lower-alkoxy-lower-alkylcarbonoyloxy, lower-alkylaminocarbonyloxy, arylaminocarbonyloxy or aryl-lower alkylaminocarbonyloxy, X is C1-C18-alkylene which optionally can be interrupted by 1,4-phenylene or interrupted or lengthened by 1,4-cyclohexylene, A is di- or tri-substituted 2-imidazolyl attached via an ethylene group or a substituted or unsubstituted heterocycle selected from the group consisting of benzimidazolyl, benzimidazolonyl, imidazo[4,5-c]pyridinyl, imidazo[4,5-c]pyridinonyl, benzthiazolyl, benzodiazepine-2,5-dion-1-yl and pyrrolo[2,1-c]-[1,4]benzodiazepine-5,11-dion-10-yl and n is the number 0 or 1, in the form of racemates and optical antipodes, as well as N-oxides and pharmaceutically usable acid addition salts thereof. The compounds of formual I have a pronounced calcium-antagonistic and anti-arrhythmic activity and can accordingly be used as medicaments, especially for the control or prevention of angina pectoris, ischaemia, arrhythmias, high blood pressure and cardiac insufficiency.
Patent DE-1800240-B2 (DE)
Title: Servo-assisted safety valve - has stepped hollow closing element with lid and sliding on stationary piston
IPC: F16K17/10
Filed: 1968-10-01
Abstract: The steam safety valves is for power station operations, and consists of housing (1) with inlet and outlet connections. The working pressure acts via drillings (4) onto space (5) and loads the closing element (6) in direction of closing. The closing element slides on the stationary piston (9) fitted with an axial drilling. Piston (9) forms with the cylindrical closing element (6) a damping chamber located on the side adjacent to the valve seat. The hollow closing element is closed up at one end by lid (6) and the housing on this side is extended to form space (5) from which a flanged extension connects to the governor valve arrangement (20). To operate the safety valve control pressure is built-up, which lifts the governor valve (20).